Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%
- Check23 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.2%
- Check37 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has been updated to include new facility names, locations, and several important drug-related topics, while removing outdated location details and certain medical terms. Notably, the addition of recent studies on pembrolizumab and related drugs enhances the page's relevance in the context of cancer treatment.SummaryDifference6%
- Check66 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.